126 related articles for article (PubMed ID: 8191598)
21. [Radiotherapy of glioblastoma].
de Crevoisier R; Pierga JY; Dendale R; Feuvret L; Noël G; Simon JM; Mazeron JJ
Cancer Radiother; 1997; 1(3):194-207. PubMed ID: 9295873
[TBL] [Abstract][Full Text] [Related]
22. Interstitial 252Cf neutron therapy for glioblastoma multiforme.
Maruyama Y; Chin HW; Young AB; Bean J; Tibbs P; Beach JL
Am J Clin Oncol; 1982 Dec; 5(6):589-91. PubMed ID: 6299091
[TBL] [Abstract][Full Text] [Related]
23. Intracranial arterial occlusion associated with high-activity iodine-125 brachytherapy for glioblastoma.
Bernstein M; Lumley M; Davidson G; Laperriere N; Leung P
J Neurooncol; 1993 Sep; 17(3):253-60. PubMed ID: 8164061
[TBL] [Abstract][Full Text] [Related]
24. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
[TBL] [Abstract][Full Text] [Related]
25. Treatment of recurrent glioblastoma with stereotactic radiotherapy: long-term results of a mono-institutional trial.
Maranzano E; Anselmo P; Casale M; Trippa F; Carletti S; Principi M; Loreti F; Italiani M; Caserta C; Giorgi C
Tumori; 2011; 97(1):56-61. PubMed ID: 21528665
[TBL] [Abstract][Full Text] [Related]
26. Experimental iodine-125 seed irradiation of intracerebral brain tumors in nude mice.
Verhoeff JJ; Stalpers LJ; Coumou AW; Koedooder K; Lavini C; Van Noorden CJ; Haveman J; Vandertop WP; van Furth WR
Radiat Oncol; 2007 Sep; 2():38. PubMed ID: 17897452
[TBL] [Abstract][Full Text] [Related]
27. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study.
Sur RK; Levin CV; Donde B; Sharma V; Miszczyk L; Nag S
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):127-33. PubMed ID: 12007950
[TBL] [Abstract][Full Text] [Related]
28. Survival and functional status after resection of recurrent glioblastoma multiforme.
Barker FG; Chang SM; Gutin PH; Malec MK; McDermott MW; Prados MD; Wilson CB
Neurosurgery; 1998 Apr; 42(4):709-20; discussion 720-3. PubMed ID: 9574634
[TBL] [Abstract][Full Text] [Related]
29. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
30. Irradiation fields and doses in glioblastoma multiforme: are current standards adequate?
Reni M; Cozzarini C; Panucci MG; Ceresoli GL; Ferreri AJ; Fiorino C; Truci G; Falini A; Tartara F; Terreni MR; Verusio C; Villa E
Tumori; 2001; 87(2):85-90. PubMed ID: 11401212
[TBL] [Abstract][Full Text] [Related]
31. External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2.
Gutin PH; Prados MD; Phillips TL; Wara WM; Larson DA; Leibel SA; Sneed PK; Levin VA; Weaver KA; Silver P
Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):601-6. PubMed ID: 1651302
[TBL] [Abstract][Full Text] [Related]
32. Work in progress: 252Cf neutron brachytherapy for hemispheric malignant glioma.
Maruyama Y; Chin HW; Young AB; Beach JL; Bean J; Tibbs P
Radiology; 1982 Oct; 145(1):171-4. PubMed ID: 6289375
[TBL] [Abstract][Full Text] [Related]
33. Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme.
Patel S; Breneman JC; Warnick RE; Albright RE; Tobler WD; van Loveren HR; Tew JM
Neurosurgery; 2000 May; 46(5):1123-8; discussion 1128-30. PubMed ID: 10807244
[TBL] [Abstract][Full Text] [Related]
34. Radiotherapy of glioblastoma multiforme. Feasibility of increased fraction size and shortened overall treatment.
Lang O; Liebermeister E; Liesegang J; Sautter-Bihl ML
Strahlenther Onkol; 1998 Dec; 174(12):629-32. PubMed ID: 9879350
[TBL] [Abstract][Full Text] [Related]
35. Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?
Morton G; Loblaw A; Cheung P; Szumacher E; Chahal M; Danjoux C; Chung HT; Deabreu A; Mamedov A; Zhang L; Sankreacha R; Vigneault E; Springer C
Radiother Oncol; 2011 Sep; 100(3):463-7. PubMed ID: 21924511
[TBL] [Abstract][Full Text] [Related]
36. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme.
Sneed PK; Stauffer PR; McDermott MW; Diederich CJ; Lamborn KR; Prados MD; Chang S; Weaver KA; Spry L; Malec MK; Lamb SA; Voss B; Davis RL; Wara WM; Larson DA; Phillips TL; Gutin PH
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):287-95. PubMed ID: 9457811
[TBL] [Abstract][Full Text] [Related]
37. Postoperative radiotherapy for glioblastoma multiforme.
Lin JC; Jan JS
Zhonghua Yi Xue Za Zhi (Taipei); 1992 Dec; 50(6):454-62. PubMed ID: 1338021
[TBL] [Abstract][Full Text] [Related]
38. Interstitial iridium-192 implantation for malignant brain tumours. Part II: Clinical experience.
Chun M; McKeough P; Wu A; Kasdon D; Heros D; Chang H
Br J Radiol; 1989 Feb; 62(734):158-62. PubMed ID: 2538197
[TBL] [Abstract][Full Text] [Related]
39. Fractionated brachytherapy: catheter insertion and dosimetry.
Gildenberg PL; Woo S; Butler B; Grant W; Berner B
Stereotact Funct Neurosurg; 1994; 63(1-4):246-9. PubMed ID: 7624641
[TBL] [Abstract][Full Text] [Related]
40. Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme.
Larson DA; Suplica JM; Chang SM; Lamborn KR; McDermott MW; Sneed PK; Prados MD; Wara WM; Nicholas MK; Berger MS
Neuro Oncol; 2004 Apr; 6(2):119-26. PubMed ID: 15134626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
